08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
The ADA Amendments Act of 2008 substantially expanded the definition of protected disabled persons u...
Read More >
Royal Mail has successfully persuaded the United Kingdom’s Court of Appeal to uphold an injunction ...
Read More >
Despite unprecedented disruptions to the court system from the COVID-19 pandemic, plaintiffs continu...
Read More >
Many of our readers are aware of the ConsensusDocs family of construction industry contract template...
Read More >
For contractors and subcontractors, late payments can be an all-too-familiar part of the constructio...
Read More >
Physician practice acquisitions and/or equity investment by nontraditional players, such as health p...
Read More >